Inovio Pharmaceuticals, Inc. (INO)

1.43 +0.07 (+5.15%) USD  |  NASDAQ  |  Sep 04, 16:00
1.42 -0.01 (-0.70%) Pre-Market: 20:00
More

Inovio Pharmaceuticals SG&A Expense (TTM) : 30.77M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for INO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 30.77M
March 31, 2026 31.54M
December 31, 2025 32.68M
September 30, 2025 33.07M
June 30, 2025 33.80M
March 31, 2025 35.45M
December 31, 2024 36.99M
September 30, 2024 39.64M
June 30, 2024 40.95M
March 31, 2024 44.26M
December 31, 2023 47.58M
September 30, 2023 51.29M
June 30, 2023 53.19M
March 31, 2023 88.12M
December 31, 2022 90.19M
September 30, 2022 90.28M
June 30, 2022 91.62M
March 31, 2022 55.82M
December 31, 2021 53.75M
September 30, 2021 48.32M
June 30, 2021 45.28M
March 31, 2021 43.68M
December 31, 2020 37.25M
September 30, 2020 37.33M
June 30, 2020 32.90M
Date Value
March 31, 2020 27.68M
December 31, 2019 27.20M
September 30, 2019 24.14M
June 30, 2019 25.25M
March 31, 2019 26.59M
December 31, 2018 29.32M
September 30, 2018 31.71M
June 30, 2018 31.24M
March 31, 2018 30.22M
December 31, 2017 28.29M
September 30, 2017 27.22M
June 30, 2017 26.66M
March 31, 2017 26.29M
December 31, 2016 23.89M
September 30, 2016 21.79M
June 30, 2016 20.41M
March 31, 2016 19.33M
December 31, 2015 18.06M
September 30, 2015 17.43M
June 30, 2015 16.20M
March 31, 2015 15.83M
December 31, 2014 15.86M
September 30, 2014 15.97M
June 30, 2014 16.10M
March 31, 2014 14.80M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Fortress Biotech, Inc. 68.84M
Tonix Pharmaceuticals Holding Corp. 125.96M
Kura Oncology, Inc. 135.28M
Spero Therapeutics, Inc. 19.85M
ACADIA Pharmaceuticals, Inc. 620.29M